{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T16:52:04Z","timestamp":1776617524373,"version":"3.51.2"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1097\/mph.0000000000000283","type":"journal-article","created":{"date-parts":[[2014,11,6]],"date-time":"2014-11-06T05:25:13Z","timestamp":1415251513000},"page":"322-326","source":"Crossref","is-referenced-by-count":12,"title":["Successful T-cell\u2013depleted Haploidentical Hematopoietic Stem Cell Transplantation in a Child With Dyskeratosis Congenita After a Fludarabine-based Conditioning Regimen"],"prefix":"10.1097","volume":"37","author":[{"given":"Mattia","family":"Algeri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Comoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Strocchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesare","family":"Perotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Corbella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Del Fante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambrogia","family":"Baio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Giorgiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Gurrado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Accornero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Cugno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Pession","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Zecca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-18-20210209","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/asheducation-2011.1.480","article-title":"Dyskeratosis congenita.","volume":"1","author":"Dokal","year":"2011","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"key":"R2-18-20210209","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1016\/j.febslet.2010.05.019","article-title":"Dyskeratosis congenita.","volume":"584","author":"Bessler","year":"2010","journal-title":"FEBS Lett"},{"key":"R3-18-20210209","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.hoc.2009.01.003","article-title":"Dyskeratosis congenita.","volume":"23","author":"Savage","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"key":"R4-18-20210209","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ppul.22528","article-title":"A patient with X-linked dyskeratosis congenita presenting with bronchiolitis obliterans requiring lung transplantation and immunodeficiency.","volume":"48","author":"Goldfarb","year":"2013","journal-title":"Pediatr Pulmonol"},{"key":"R5-18-20210209","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4046\/trd.2013.74.2.70","article-title":". Interstitial lung disease in a patient with dyskeratosis congenita.","volume":"74","author":"Kim","year":"2013","journal-title":"Tuberc Respir Dis"},{"key":"R6-18-20210209","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/ijc.28157","article-title":". Squamous cell carcinomas in patients with Fanconi anemia and dyskeratosis congenita: a search for human papillomavirus.","volume":"133","author":"Alter","year":"2013","journal-title":"Int J Cancer"},{"key":"R7-18-20210209","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1399-3046.2007.00721.x","article-title":"Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation.","volume":"11","author":"De la Fuente","year":"2007","journal-title":"Pediatr Transpl"},{"key":"R8-18-20210209","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1046\/j.1365-2141.1996.424984.x","article-title":". Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita.","volume":"92","author":"Langston","year":"1996","journal-title":"Br J Haematol"},{"key":"R9-18-20210209","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-2141.1998.00949.x","article-title":". Unusual complications after bone marrow transplantation for dyskeratosis congenita.","volume":"103","author":"Rocha","year":"1998","journal-title":"Br J Haematol"},{"key":"R10-18-20210209","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/bmt.2010.65","article-title":". Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita.","volume":"46","author":"Dietz","year":"2011","journal-title":"Bone Marrow Transpl"},{"key":"R11-18-20210209","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/j.1600-6143.2007.01823.x","article-title":". Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation.","volume":"7","author":"Comoli","year":"2007","journal-title":"Am J Transpl"},{"key":"R12-18-20210209","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/sj.bmt.1703931","article-title":". Low-intensity hematopoietic stem-cell transplantation across human leucocyte antigen barriers in dyskeratosis congenita.","volume":"31","author":"Dror","year":"2003","journal-title":"Bone Marrow Transpl"},{"key":"R13-18-20210209","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/sj.bmt.1705171","article-title":". Fatal diffuse capillaritis after hematopoietic stem-cell transplantation for dyskeratosis congenita despite low-intensity conditioning regimen.","volume":"36","author":"Brazzola","year":"2005","journal-title":"Bone Marrow Transpl"},{"key":"R14-18-20210209","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/sj.bmt.1705839","article-title":". Late death after unrelated-BMT for dyskeratosis congenita following conditioning with alemtuzumab, fludarabine and melphalan.","volume":"40","author":"Amarasinghe","year":"2007","journal-title":"Bone Marrow Transpl"},{"key":"R15-18-20210209","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0140-6736(09)60945-4","article-title":". Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 12 study.","volume":"374","author":"Straathof","year":"2009","journal-title":"Lancet"},{"key":"R16-18-20210209","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/bmt.2008.163","article-title":". Unrelated cord blood transplantation in a girl with Hoyeraal-Hreidarsson syndrome.","volume":"42","author":"Coman","year":"2008","journal-title":"Bone Marrow Transpl"},{"key":"R17-18-20210209","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-2141.2008.07364.x","article-title":". Double cord blood transplantation in patients with high risk bone marrow failure syndromes.","volume":"143","author":"Ruggeri","year":"2008","journal-title":"Br J Haematol"},{"key":"R18-18-20210209","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1399-3046.2010.01431.x","article-title":". Reduced-intensity conditioning for alternative donor hematopoietic stem cell transplantation in patients with dyskeratosis congenita.","volume":"15","author":"Nishio","year":"2011","journal-title":"Pediatr Transpl"},{"key":"R19-18-20210209","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000318721","article-title":". Reduced-intensity conditioning using fludarabine and antithymocyte globulin alone allows stable engraftment in a patient with dyskeratosis congenita.","volume":"124","author":"Vuong","year":"2010","journal-title":"Acta Haematol"},{"key":"R20-18-20210209","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/bmt.2013.35","article-title":". Reduced intensity conditioning is effective for hematopoietic SCT in dyskeratosis congenita-related BM failure.","volume":"48","author":"Ayas","year":"2013","journal-title":"Bone Marrow Transpl"},{"key":"R21-18-20210209","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3324\/haematol.11436","article-title":". The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group.","volume":"92","author":"Locatelli","year":"2007","journal-title":"Haematologica"},{"key":"R22-18-20210209","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1365-2141.2007.06975.x","article-title":". Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia.","volume":"140","author":"Chaudhury","year":"2008","journal-title":"Br J Haematol"},{"key":"R23-18-20210209","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.bbmt.2006.11.015","article-title":". Fludarabine, cyclophosphamide, and antithymocyte globulin for a patient with dyskeratosis congenita and severe bone marrow failure.","volume":"13","author":"Ostronoff","year":"2007","journal-title":"Biol Blood Marrow Transpl"},{"key":"R24-18-20210209","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/pbc.20696","article-title":". Allogeneic stem cell transplantation in a patient with dyskeratosis congenita after conditioning with low-dose cyclophosphamide and anti-thymocyte globulin.","volume":"49","author":"Ayas","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R25-18-20210209","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.bbmt.2012.04.014","article-title":". Fludarabine-based conditioning for marrow transplantation form unrelated donor in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels.","volume":"18","author":"Tolar","year":"2012","journal-title":"Biol Blood Marrow Transpl"},{"key":"R26-18-20210209","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/pbc.20538","article-title":". Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation.","volume":"46","author":"Tan","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"R27-18-20210209","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00043426-199905000-00013","article-title":". Fludarabine-based protocol for human umbilical cord blood transplantation in children with Fanconi anemia.","volume":"21","author":"Aker","year":"1999","journal-title":"J Pediatr Hematol Oncol"},{"key":"R28-18-20210209","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.bbmt.2011.01.001","article-title":". Bone marrow transplantation for Fanconi anemia using fludarabine-based conditioning.","volume":"17","author":"Stepensky","year":"2011","journal-title":"Biol Blood Marrow Transpl"},{"key":"R29-18-20210209","first-page":"298","article-title":"Alternate donor HCT for fanconi anemia (FA): results of a total body irradiation (TBI) dose de-escalation study.","volume":"1","author":"MacMillan","year":"2008","journal-title":"Blood ASH Ann Meet Abst"},{"key":"R30-18-20210209","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.exphem.2004.05.026","article-title":". Intra-bone marrow injection of bone marrow and cord blood cells: an alternative way of transplantation associated with a higher seeding efficiency.","volume":"32","author":"Castello","year":"2004","journal-title":"Exp Hematol"},{"key":"R31-18-20210209","first-page":"237","article-title":". The intra-bone marrow injection of cord blood cells extends the possibility of transplantation to the majority of patients with malignant hematopoietic diseases. Best Pr.","volume":"23","author":"Frassoni","year":"2010","journal-title":"Res Clin Haematol"},{"key":"R32-18-20210209","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ajhg.2007.10.004","article-title":". TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita.","volume":"82","author":"Savage","year":"2008","journal-title":"Am J Hum Genet"},{"key":"R33-18-20210209","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cancergen.2011.11.002","article-title":"The genetics of dyskeratosis congenita.","volume":"204","author":"Mason","year":"2011","journal-title":"Cancer Genet"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000000283","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T19:41:24Z","timestamp":1717530084000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201505000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000283","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}